Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is a relatively rare

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It

Specialty biopharmaceutical company Biovest

The European Commission approved the drug Velcade (bortezomib) for the treatment of

Next up in the Leukemia & Lymphoma Society's free telephone/web education programs

Mantle cell lymphoma remains one of the more elusive subtypes of

Because science has only recently became familiar with mantle cell lymphoma, there aer not

Mantle cell lymphoma (MCL), a rare disease that has been difficult to study in clinical

Mantle cell lymphoma (MCL) is a very rare and difficult to

Among the many fairly commonly mentioned subtypes of non-Hodgkin

Scientists have undertaken the first truly comprehensive analysis of

Results of a recently published Phase II study by Italian researchers indicate that

The U.S. Food and Drug Administration today has approved Imbruvica (ibrutinib) for the